Repro Med Systems, Inc. (NASDAQ:KRMD) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Greg Chodaczek - Managing Director Linda Tharby - President & CEO Karen Fisher - CFO, Treasurer & Corporate Secretary Conference Call Participants Chase Knickerbocker - Craig-Hallum Joseph Downing - Piper Sandler & Co. Operator Greetings, and welcome to KORU Medical Systems' First Quarter 2022 Earnings Conference Call. [Operator Instructions]. As a reminder, this conference is being recorded. I ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2022 or [_] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________. Commission File Number: 0-12305 Securities registered pursuant to Section 12(b) of the Act: | Title of each class | Trading Symbol(s ...

Repro Med Systems, Inc. (NASDAQ:KRMD) Q4 2021 Earnings Conference Call March 2, 2022 4:30 PM ET Company Participants Greg Chodaczek - IR Linda Tharby - President and CEO Karen Fisher - CFO Conference Call Participants Alex Nowak - Craig Hallum Capital Operator Greetings. Welcome to KORU Medical Systems Fourth Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation . [Operator instructions] Please note, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to __________ Commission file number 0-12305 REPRO MED SYSTEMS, INC. (Exact name of registrant as specified in its charter) NEW YORK 13-3044880 (State or other jur ...

Repro Med Systems, Inc. (NASDAQ:KRMD) Q3 2021 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Greg Chodaczek - IR Linda Tharby - President and CEO Karen Fisher - CFO Conference Call Participants Trenton McCarthy - Craig-Hallum Capital Group Operator Good day. And welcome to KORU Medical Systems Third Quarter 2021 Earnings Conference Call and Webcast. All participants will be in a listen-only mode. [Operator instructions]. Please note, this event is being recorded. I would now like ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2021 or [_] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________. Commission File Number: 0-12305 REPRO MED SYSTEMS, INC. (Exact name of registrant as specified in its charter) New York 13-30448 ...

KORU Medical Systems, Inc. (NASDAQ:KRMD) Q2 2021 Earnings Conference Call August 11, 2021 4:30 PM ET Company Participants Linda Tharby - President & Chief Executive Officer Karen Fisher - Chief Financial Officer Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Operator Greetings. And welcome to KORU Medical Systems Second Quarter 2021 Financial Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the form ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2021 or [_] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________. (Former name, former address and former fiscal year, if changed since last report) Commission File Number: 0-12305 REPRO MED SYSTEMS, ...

KORU Medical Systems (NASDAQ:KRMD) Q1 2021 Earnings Conference Call May 12, 2021 4:30 PM ET Company Participants Greg Chodaczek - Investor Relations Linda Tharby - President and Chief Executive Officer Karen Fisher - Chief Financial Officer Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Kyle Rose - Canaccord Operator Greetings. Welcome to the KORU Medical Systems First Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 0-12305 REPRO MED SYSTEMS, INC. (Exact name of registrant as specified in its charter) New York 13-3044880 For the Quarterly Period Ended March 31, 2021 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________. ( ...